Status
Conditions
Treatments
About
This postmarket registry is intended to prospectively collect real world data to support ongoing safety and performance of the SpineJack system.
Full description
The SpineJack System Registry will employ a prospective, multicenter, observational, consecutive enrollment design. The sample size for this Registry will include at least 400 patients treated for VCFs across approximately 10 sites. A total of 240 patients will be treated with the SpineJack system and 160 patients will be treated with other vertebral augmentation (VA) procedures, such as BKP or VP. Sites within the U.S. may include healthcare professionals (HCPs) that are surgeons, pain physicians and/or interventional radiologists.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
261 participants in 2 patient groups
Loading...
Central trial contact
Raffaella Falciglia; Jessica Ward
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal